Robert Booth - Jan 2, 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Bhaskar Anand, as Attorney-in-Fact for Robert Booth
Stock symbol
SMMT
Transactions as of
Jan 2, 2025
Transactions value $
$62,929
Form type
4
Date filed
1/6/2025, 06:57 PM
Previous filing
Jan 4, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +35K 35K Jan 2, 2025 Common Stock 35K $18.35 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award $62.9K +6.86K $9.18 6.86K Jan 2, 2025 Common Stock 6.86K $18.35 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 2, 2025. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date.
F2 Not applicable.
F3 The option was granted on January 2, 2025. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date.
F4 The option was issued to the reporting person pursuant to the Director Retainer Option Election Plan of issuer in lieu of retainer fees of $62,900.

Remarks:

Exhibit 24 - Power of Attorney